C. Bertagna

1.0k total citations
19 papers, 795 citations indexed

About

C. Bertagna is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, C. Bertagna has authored 19 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in C. Bertagna's work include Prostate Cancer Treatment and Research (10 papers), Hormonal and reproductive studies (8 papers) and Estrogen and related hormone effects (4 papers). C. Bertagna is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Hormonal and reproductive studies (8 papers) and Estrogen and related hormone effects (4 papers). C. Bertagna collaborates with scholars based in France, United States and United Kingdom. C. Bertagna's co-authors include David N. Orth, Jean‐Marc Husson, Xavier Bertagna, François Girard, Jean-Pierre Luton, Jean Fiet, M H Laudat, R Dahan, A Moulonguet and Pierre Costa and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

C. Bertagna

18 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bertagna France 11 484 245 185 117 114 19 795
R B Jaffe United States 9 117 0.2× 86 0.4× 91 0.5× 177 1.5× 50 0.4× 10 483
M C Sheppard United Kingdom 16 1.0k 2.1× 55 0.2× 141 0.8× 301 2.6× 217 1.9× 35 1.4k
Saija Salmi Finland 5 209 0.4× 176 0.7× 58 0.3× 136 1.2× 342 3.0× 6 588
Diana M. Malchoff United States 13 552 1.1× 60 0.2× 168 0.9× 197 1.7× 287 2.5× 23 867
J. M. Jacobi Australia 13 361 0.7× 45 0.2× 77 0.4× 106 0.9× 129 1.1× 23 614
J.M.P. Holly United Kingdom 21 785 1.6× 60 0.2× 93 0.5× 395 3.4× 201 1.8× 33 1.2k
Jaime Steinsapir United States 10 335 0.7× 54 0.2× 114 0.6× 144 1.2× 126 1.1× 20 506
Nacia Faure Canada 18 284 0.6× 122 0.5× 32 0.2× 182 1.6× 100 0.9× 38 876
Hany Soliman France 15 190 0.4× 117 0.5× 170 0.9× 209 1.8× 40 0.4× 27 728
Silvia Einaudi Italy 16 386 0.8× 121 0.5× 148 0.8× 465 4.0× 274 2.4× 30 903

Countries citing papers authored by C. Bertagna

Since Specialization
Citations

This map shows the geographic impact of C. Bertagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bertagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bertagna more than expected).

Fields of papers citing papers by C. Bertagna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bertagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bertagna. The network helps show where C. Bertagna may publish in the future.

Co-authorship network of co-authors of C. Bertagna

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bertagna. A scholar is included among the top collaborators of C. Bertagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bertagna. C. Bertagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Crawford, Emily, James Smith, Mark S. Soloway, et al.. (1990). A randomized controlled clinical trial of leuprolide and anandron versus leuprolide and placebo for advanced prostate cancer. 221. 13 indexed citations
4.
Kuhn, Jean‐Marc, T Billebaud, H Navratil, et al.. (1989). Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide). New England Journal of Medicine. 321(7). 413–418. 159 indexed citations
5.
Pendyala, Lakshmi, et al.. (1988). Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostate. Cancer Chemotherapy and Pharmacology. 22(1). 69–76. 10 indexed citations
6.
Bertagna, Xavier, et al.. (1988). PERIPHERAL ANTIGLUCOCORTICOID ACTION OF RU 486 IN MAN. Clinical Endocrinology. 28(5). 537–541. 14 indexed citations
7.
Moguilewsky, M., et al.. (1987). Pharmacological and clinical studies of the antiandrogen Anandron. Journal of Steroid Biochemistry. 27(4-6). 871–875. 19 indexed citations
8.
Pendyala, Lakshmi, Creaven Pj, Robert P. Huben, et al.. (1987). Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908).. PubMed. 243A. 351–63. 5 indexed citations
9.
Namer, M., Jeanne Amiel, J.E. Couette, et al.. (1987). Orchiectomy associated with anandron (RU23, 908) or placebo in treatment of stage D prostate cancer: Preliminary resultsof a randomized, double-blind french cooperative study. European Journal of Cancer and Clinical Oncology. 23(8). 1246–1246. 1 indexed citations
10.
Fiet, Jean, et al.. (1987). Plasma hormone levels before and after orchiectomy in prostate cancer patients.. PubMed. 243A. 33–44. 7 indexed citations
11.
Bertagna, C., et al.. (1987). Endocrine effects of the pure antiandrocen anandronR in castrated patients with metastatic prostatic cancer. European Journal of Cancer and Clinical Oncology. 23(8). 1233–1233. 2 indexed citations
12.
Kuhn, Jean‐Marc, C. Bertagna, T Billebaud, et al.. (1987). Combining the antiandrogen anandronR with LHRH agonist; Sequential assays of hormones and prostate markers during a double-blind study. European Journal of Cancer and Clinical Oncology. 23(8). 1243–1243. 2 indexed citations
13.
Bertagna, Xavier, C. Bertagna, M H Laudat, et al.. (1986). Pituitary-Adrenal Response to the Antiglucocorticoid Action of RU 486 in Cushing's Syndrome*. The Journal of Clinical Endocrinology & Metabolism. 63(3). 639–643. 82 indexed citations
14.
15.
Raynaud, Jean‐Pierre, M. Moguilewsky, C. Tournemine, et al.. (1985). Pharmacology and clinical studies with RU 23908 (Anandron).. PubMed. 185A. 99–120. 12 indexed citations
16.
Bertagna, C., et al.. (1985). Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism. European Journal of Clinical Pharmacology. 28(5). 531–535. 14 indexed citations
17.
Bertagna, Xavier, C. Bertagna, Jean-Pierre Luton, Jean‐Marc Husson, & François Girard. (1984). The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man. The Journal of Clinical Endocrinology & Metabolism. 59(1). 25–28. 194 indexed citations
18.
Krieger, J, et al.. (1983). Hypnotic benzodiazepines: Relationship between sleep parameters and pharmacokinetics of loprazolam. Drug Development Research. 3(2). 143–152. 9 indexed citations
19.
Bertagna, C. & David N. Orth. (1981). Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). The American Journal of Medicine. 71(5). 855–875. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R B Jaffe Breakdown of academic impact, for papers by M C Sheppard Breakdown of academic impact, for papers by Saija Salmi Breakdown of academic impact, for papers by Diana M. Malchoff Breakdown of academic impact, for papers by J. M. Jacobi Breakdown of academic impact, for papers by J.M.P. Holly Breakdown of academic impact, for papers by Jaime Steinsapir Breakdown of academic impact, for papers by Nacia Faure Breakdown of academic impact, for papers by Hany Soliman Breakdown of academic impact, for papers by Silvia Einaudi
Rankless by CCL
2026